Pfizer investing $1b in new pharmaceutical ingredient plant in Singapore, creating 250 jobs
newsare.net
SINGAPORE — US pharmaceutical giant Pfizer opened its new $1 billion plant in Singapore on Tuesday (July 23). The 429,000 sq ft plant in Tuas Biomedical Park will produce the active pharmaceutical ingredient (API) — the biologically active component oPfizer investing $1b in new pharmaceutical ingredient plant in Singapore, creating 250 jobs
SINGAPORE — US pharmaceutical giant Pfizer opened its new $1 billion plant in Singapore on Tuesday (July 23). The 429,000 sq ft plant in Tuas Biomedical Park will produce the active pharmaceutical ingredient (API) — the biologically active component of a drug — for Pfizer's cancer, pain, and antibiotic medicines. The new investment will create 250 new highly skilled jobs, said the company. Pfizer said the state-of-the-art facility, an extension of its 20-year-old site in Singapore, has passed all necessary final performance qualification checks and begun commercial manufacturing of products. The facility has also achieved a Green Mark gold certification, a Singapore accreditation for environmental sustainability, and will help Pfizer's goal to achieve the voluntary net-zero standard by 2040. Mike McDermott, chief global supply officer and executive vice-president of Pfizer, said the new plant will be one of the most highly automated among the company's more than 30 manufacturing sites, which are spread across six continents. Read more